TCL Archive With $1.1 Billion At Stake, Cancer Groups Mull Comparative Effectiveness Studies May 22, 2009
TCL Archive FDA Says Bristol’s UFT “Not Approvable” For Colorectal Cancer, Contrary To ODAC. March 30, 2001
